Abstract

Summary

This roadmap paper from the RReSTORe Consortium outlines strategies for repopulating retinal ganglion cells (RGCs) lost to glaucoma and other optic neuropathies, addressing the CNS's limited regenerative capacity. For lighting and healthcare professionals, restoration of RGC populations—including ipRGCs—could eventually recover not only visual function but also circadian light-sensing capabilities in affected patients.
Abstract

Key Findings

  • RGC death in glaucoma and optic neuropathies causes irreversible vision loss due to the mammalian CNS's inability to regenerate these cells naturally.
  • The consortium identifies a multi-step roadmap for RGC repopulation therapy, encompassing cell replacement, axon regeneration, and synaptic reconnection as key challenges.
  • No specific quantitative experimental outcomes reported; paper is a strategic review/roadmap document.
Categories

Categories

Eye Health & Vision: Directly addresses retinal ganglion cell death in glaucoma and optic neuropathies, with implications for vision restoration.
The Science of Light: RGCs include intrinsically photosensitive cells (ipRGCs) relevant to non-image-forming light detection and circadian photoentrainment.
Authors

Author(s)

JR Soucy, EA Aguzzi, J Cho, MJ Gilhooley
Publication Date

Publication Year

2023
Citations

Number of Citations

4
View more publications